Assess Safety and Compare PK of New Oral hPTH(1-34) Tablet Formulations vs. EBP05 Tablets and Subcutaneous Forteo

Clinical trial NCT05965167 · COMPLETED

Trial details

NCT number: NCT05965167
Sponsor: Entera Bio Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hypoparathyroidism Osteoporosis Fractures, Bone Other Disease

Start date: 2023-05-11
Primary completion: 2026-02-08
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.